AEVI GENOMIC MEDICINE

Welcome to the Brand page for “AEVI GENOMIC MEDICINE”, which is offered here for Pharmaceutical products, treatments for pediatric onset and rare and orphan disorders; biological and chemical preparations for medical and veterinary use; antibodies for medical and veterinary use; proteins, enzymes, and peptides for medical and veterinary use; small molecule drugs for use in treatments for pediatric onset and rare and orphan disorders; reagents for medical use; diagnostic reagents and diagnostic assays for medical use; therapeutic agents for use in treatments for pediatric onset and rare and orphan disorders; immunotherapeutics and immunologics for use in treatments for pediatric onset and rare and orphan disorders; viral, retroviral, and non-viral vectors for use in treatments for pediatric onset and rare and orphan disorders; vaccines; adjuvants; pharmaceutical preparations for the treatment of rare and difficult-to-treat diseases; biological materials, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;reagents for research purposes; assays for research purposes;medical services, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes; medical services;medical devices and instruments for genetically modifying tissue;genomic medicine;medical research; pharmaceutical drug development services; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “AEVI GENOMIC MEDICINE” is believed to be currently owned by “AEVI GENOMIC MEDICINE, INC.”

Owner:
AEVI GENOMIC MEDICINE, INC.
Owner Details
Description:
Pharmaceutical products, treatments for pediatric onset and rare and orphan disorders; biological and chemical preparations for medical and veterinary use; antibodies for medical and veterinary use; proteins, enzymes, and peptides for medical and veterinary use; small molecule drugs for use in treatments for pediatric onset and rare and orphan disorders; reagents for medical use; diagnostic reagents and diagnostic assays for medical use; therapeutic agents for use in treatments for pediatric onset and rare and orphan disorders; immunotherapeutics and immunologics for use in treatments for pediatric onset and rare and orphan disorders; viral, retroviral, and non-viral vectors for use in treatments for pediatric onset and rare and orphan disorders; vaccines; adjuvants; pharmaceutical preparations for the treatment of rare and difficult-to-treat diseases; biological materials, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;Reagents for research purposes; assays for research purposes;Medical services, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes; medical services;Medical devices and instruments for genetically modifying tissue;GENOMIC MEDICINE;Medical research; pharmaceutical drug development services; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;
Categories: PHARMACEUTICAL PRODUCTS